Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: Results of the European Heart Rhythm Association survey

36Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73%) centres performed ≤10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being 'the patient has absolute contraindication to long term oral anticoagulants'. Among survey respondents, LAAO procedures are most often performed by interventional cardiologists. Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, bleeding) complications reported by the respondents to this EP wire survey. © The Author 2012.

Cite

CITATION STYLE

APA

Lip, G. Y. H., Dagres, N., Proclemer, A., Svendsen, J. H., Pison, L., & Blomstrom-Lundqvist, C. (2013, January). Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: Results of the European Heart Rhythm Association survey. Europace. https://doi.org/10.1093/europace/eus413

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free